Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis

International Journal of Cancer

Volumn 123, Issue 2, 2008, Pages 430-435

  Evans, Simon ^a,c   Metcalfe, Chris ^a   Ibrahim, Fowzia ^a,d   Persad, Raj ^b   Ben Shlomo, Yoav ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

^c ROYAL UNITED HOSPITAL   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Ethnicity; Meta analysis; Prognosis; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BIOCHEMISTRY; CANCER RECURRENCE; CANCER SCREENING; CANCER SURVIVAL; CAUCASIAN; COMORBIDITY; CONFIDENCE INTERVAL; ETHNIC DIFFERENCE; HEALTH CARE ACCESS; HUMAN; NEGRO; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RACE DIFFERENCE; RISK ASSESSMENT; SOCIOECONOMICS; SYSTEMATIC REVIEW; AFRICAN AMERICAN; AGE; AGED; EPIDEMIOLOGY; ETHNOLOGY; MALE; META ANALYSIS; METHODOLOGY; MIDDLE AGED; MORTALITY; PROSTATE TUMOR; REVIEW; RISK; RISK FACTOR; SOCIAL CLASS; STATISTICS; SURVIVAL RATE; UNITED STATES;

AFRICAN AMERICANS; AGE FACTORS; AGED; CONFOUNDING FACTORS (EPIDEMIOLOGY); EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; PROSTATIC NEOPLASMS; RESEARCH DESIGN; RISK FACTORS; SOCIAL CLASS; SURVIVAL RATE; UNITED STATES;

EID: 44949138214     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23500     Document Type: Article

References (35)

1. U.S. Cancer Statistics Working Group. United Statistics Cancer Statistics: 2002 incidence and mortality. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2005.
2. Ben-Shlomo Y, Evans S, Ibrahim F, Patel B, Anson K, Chinegwundoh F, Corbishley C, Dorling D, Thomas B, Gillatt D, Kirby R, Muir G, Nargand V, Popert R, Metcalfe C, Persad R. The risk of prostate cancer amongst Black Men in the United Kingdom: The PROCESS cohort study. Eur Urol 2008;53:99-105.
3. Aus G, Abbou CC, Bolla M, Heidenreich A, Schmid HP, van PH, Wolff J, Zattoni F. EAU guidelines on prostate cancer. Eur Urol 2005;48:546-51.
4. Evans S, Ben-Shlomo Y, Persad R. Prostate cancer in black and white men: are there differences in risk or prognosis? BJU Int 2003;92:878-9.
5. Freedland SJ, Isaacs WB. Explaining racial differences in prostate cancer in the United States: sociology or biology? Prostate 2005;62:243-52.
6. Institute of Medicine. Unequal treatment, confronting racial and ethnic disparities in healthcare. Washington, DC: The National Academies Press, 2001.
7. Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, Feuer EJ. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst 2002;94:981-90.
8. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 2002;94:334-57.
9. Shavers VL, Brown ML, Potosky AL, Klabunde CN, Davis WW, Moul JW, Fahey A. Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer. J Gen Intern Med 2004;19:146-55.
10. Davey Smith G, Neaton JD, Wentworth D, Stamler R, Stamler J. Mortality differences between black and white men in the USA: contribution of income and other risk factors among men screened for the MRFIT. Lancet 1998;351:934-9.
11. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA 2002;287:2106-13.
12. Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998;17:2815-34.
13. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
14. Legler JM, Feuer EJ, Potosky AL, Merrill RM, Kramer BS. The role of prostate-specific antigen (PSA) testing patterns in the recent pros-tate cancer incidence decline in the United States. Cancer Causes Control 1998;9:519-27.
15. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
16. Gilligan T, Wang PS, Levin R, Kantoff PW, Avorn J. Racial differences in screening for prostate cancer in the elderly. Arch Intern Med 2004;164:1858-64.
17. Mariotto AB, Etzioni R, Krapcho M, Feuer EJ. Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey. Cancer 2007;109:1877-86.
18. Cohen JH, Schoenbach VJ, Kaufman JS, Talcott JA, Schenck AP, Peacock S, Symons M, Amamoo MA, Carpenter WR, Godley PA. Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States). Cancer Causes Control 2006;17:803-11.
19. Peters N, Armstrong K. Racial differences in prostate cancer treatment outcomes: a systematic review. Cancer Nurs 2005;28:108-18.
20. Harlan L, Brawley O, Pommerenke F, Wali P, Kramer B. Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate. J Clin Oncol 1995;13:93-100.
21. Zeliadt SB, Potosky AL, Etzioni R, Ramsey SD, Penson DF. Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. Urology 2004;64:1171-6.
22. Klabunde CN, Potosky AL, Harlan LC, Kramer BS. Trends and black/white differences in treatment for nonmetastatic prostate cancer. Med Care 1998;36:1337-48.
23. Krupski TL, Kwan L, Afifi AA, Litwin MS. Geographic and socioeconomic variation in the treatment of prostate cancer. J Clin Oncol 2005;23:7881-8.
24. Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson SO, Bratell S, Spangberg A, Busch C, Nordling S, Garmo H, Palmgren J, Adami HO, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005;352:1977-84.
25. Shavers VL, Brown M, Klabunde CN, Potosky AL, Davis W, Moul J, Fahey A. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer. Med Care 2004;42:239-50.
26. Underwood W, De MS, Ubel P, Fagerlin A, Sanda MG, Wei JT. Racial/ethnic disparities in the treatment of localized/regional prostate cancer. J Urol 2004;171:1504-7.
27. Underwood W, III, Jackson J, Wei JT, Dunn R, Baker E, Demonner S, Wood DP. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999. Cancer 2005;103:538-45.
28. Hoffman RM, Harlan LC, Klabunde CN, Gilliland FD, Stephenson RA, Hunt WC, Potosky AL. Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study. J Gen Intern Med 2003;18:845-53.
29. Robbins AS, Yin D, Parikh-Patel A. Differences in prognostic factors and survival among White men and Black men with prostate cancer. California, 1995-2004. Am J Epidemiol 2007;166:71-8.
30. Asch SM, Kerr EA, Keesey J, Adams JL, Setodji CM, Malik S, McGlynn EA. Who is at greatest risk for receiving poor-quality health care? N Engl J Med 2006;354:1147-56.
31. Cruickshank JK, Heald AH, Anderson S, Cade JE, Sampayo J, Riste LK, Greenhalgh A, Taylor W, Fraser W, White A, Gibson JM. Epidemiology of the Insulin-like growth factor system in three Ethnic Groups. Am J Epidemiol 2001;154:504-13.
32. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-1. IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004;363:1346-53.
33. Chan JM, Stampfer MJ, Ma J, Gann P, Gaziano M, Pollak M, Giovannucci E. Insulin-like growth factor-I (IGF) and IGF binding protein-3 as predictors of advanced stage prostate cancer. J Natl Cancer Inst 2002;94:1099-109.
34. Oliver SE, Gunned D, Donovan J, Peters TJ, Persad R, Gillatt D, Pearce A, Neal DE, Hamdy FC, Holly J. Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study. Int J Cancer 2004;108:887-92.
35. Du XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, Xing Y, Gor BJ, Chan W. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer 2006;106:1276-85.